سعر سيديبروكت كريم 20 جم 2024

• Not known frequency: chorioretinopathy, blurred vision, adrenal suppression, urticaria, rash; anal irritation in sensitive persons.General active-ingredient information · MHRA (UK Medicines and Healthcare products Regulatory Agency)

• Known hypersensitivity to any of the ingredients; not for use in the presence of infections.General active-ingredient information · MHRA (UK Medicines and Healthcare products Regulatory Agency)

• Possible systemic absorption of the topical steroid; avoid long-term continuous therapy in infants; adrenal suppression can occur even without occlusion. Refer patients with blurred vision or other visual disturbance for ophthalmological evaluation.General active-ingredient information · MHRA (UK Medicines and Healthcare products Regulatory Agency)

• CYP3A inhibitors (including cobicistat-containing products)Expected to increase the risk of systemic corticosteroid side-effects; avoid unless benefit outweighs risk.MHRA (UK Medicines and Healthcare products Regulatory Agency)

• Topical steroids should not be used extensively in pregnancy (large amounts or long periods); animal data show fetal abnormalities of uncertain human relevance.General active-ingredient information · MHRA (UK Medicines and Healthcare products Regulatory Agency)
• Hydrocortisone may pass into breast milk; preferably not used during lactation unless benefits outweigh risks.General active-ingredient information · MHRA (UK Medicines and Healthcare products Regulatory Agency)

English text not available for this section.